SONM
DNA X, Inc.
There isn't enough reported data to score SONM yet.
SONM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Strong |
SONM's balance sheet is currently strong, and its revenue is stable, but its profitability is weak. There isn't enough data to rate its cash flow.
SONM PE Valuation
SONM has no meaningful PE right now: it lost money over the past year.
SONM Forward outlook
There aren't enough analyst estimates for SONM to show an outlook.
SONM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$23.78 | +$90.70 |
| Q1 2026 | -$37.08 | +$88.56 |
| Q4 2025 | -$40.65 | +$99.03 |
| Q3 2025 | -$109.95 | -$57.21 |
| Q2 2025 | -$114.48 | -$72.90 |
| Q1 2025 | -$125.64 | -$111.24 |
| Q4 2024 | -$139.68 | -$139.68 |
| Q3 2024 | -$52.74 | -26470% |
SONM is still losing money, but far less than before: $23.78 per share over the past year, against $2,664.00 at its worst in early 2020.
SONM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $16.2M | +7.9% |
| Q2 2025 | $11.2M | -2.8% |
| Q1 2025 | $16.7M | -0.3% |
| Q4 2024 | $15M | +12% |
| Q3 2024 | $15M | -46% |
| Q2 2024 | $11.5M | -57% |
| Q1 2024 | $16.8M | -35% |
| Q4 2023 | $13.4M | -44% |
SONM's revenue is recovering but still below its 2019 peak: $16M last quarter, up 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -25% | -8.7 points |
| Q2 2025 | -60% | -4 points |
| Q1 2025 | 3.9% | +20 points |
| Q4 2024 | -148% | -138 points |
| Q3 2024 | -16% | -18 points |
| Q2 2024 | -56% | -59 points |
| Q1 2024 | -16% | -17 points |
| Q4 2023 | -9.3% | -5 points |
SONM's operating margin was −25% last quarter, down 8.7 points from the same quarter a year ago.
SONM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2M | +$2.5M |
| Q4 2024 | -$4.5M | -$4.2M |
| Q3 2024 | -$554K | -$249K |
| Q4 2023 | -$363K | +$1.9M |
| Q3 2023 | -$305K | +$10M |
| Q4 2022 | -$2.2M | +$15.4M |
| Q4 2021 | -$17.6M | -$7.9M |
| Q4 2020 | -$9.7M | -$4.9M |
SONM has burned cash in most quarters: −$12M over the past year, against −$5M the year before.
SONM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.8% | +85.8K shares |
| 1 year | +314% | +1M shares |
| 3 years | +574% | +1.2M shares |
| 5 years | +11696% | +1.3M shares |
SONM has 1M diluted shares, up 314% from a year ago.
SONM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -3.5x | Net Cash |
| Q3 2023 | -2.6x | Net Cash |
| Q2 2023 | -7.7x | Net Cash |
SONM has more cash than debt.
SONM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.0 | Neutral |
| Stochastic | 7.9 | Oversold |
SONM's weekly RSI is 37 (neutral) and its Stochastic is 8 (oversold).
SONM PE vs Technology Sector
| Metric | SONM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
SONM has no meaningful PE right now: it lost money over the past year.
SONM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.15 | 24% below |
| 20 week MA | $3.34 | 29% below |
| 50 week MA | $4.11 | 42% below |
| 100 week MA | $15.1 | 84% below |
| 200 week MA | $65.4 | 96% below |
SONM is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
SONM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,606.0 | $1,165.3 | -82% |
| 2021 | $1,165.3 | $180.0 | -85% |
| 2022 | $180.0 | $79.2 | -56% |
| 2023 | $79.2 | $132.3 | +67% |
| 2024 | $132.3 | $55.4 | -58% |
| 2025 | $55.4 | $3.30 | -94% |
| 2026 YTD | $3.30 | $2.38 | -28% |
SONM has finished lower in five of the last six years. It's down 28% so far in 2026.